Natera
@NateraGenetics
We’re on a mission to transform the management of disease worldwide.
💙💚 This #WorldIVFDay & #WorldEmbryologistDay we celebrate the experts who help families grow. Thank you for your work and the crucial role you play in shaping the future of reproductive health. ow.ly/HSVa50WvmrO #Natera
Congratulations to Michael Brophy, #Natera’s CFO, on being named Best CFO in the public company category by the @MyABJ. Since joining Natera in 2015, Mike has played a critical role in guiding the company’s financial strategy, helping achieve cash flow breakeven in 2024 and…
Our CEO @SteveChapmanCEO underscores the growing role of renal genetic testing in helping clinicians deliver earlier, more personalized care. When we better understand a patient’s genetic risk, we can intervene sooner and change the course of disease. #ThePowerOfKnowing…
1 in 7 U.S. adults is affected by chronic kidney disease (CKD). Genetic testing enables earlier interventions, supports providers & improves outcomes. @NateraGenetics CEO & ACLA Board Member @SteveChapmanCEO shares how laboratories transform care through #ThePowerofKnowing.
Watch Natera CEO @SteveChapmanCEO on @SquawkCNBC as he shares insights on the molecular residual disease (MRD) landscape and how Signatera is helping transform care for cancer patients. cnbc.com/video/2025/07/…
We look forward to connecting at #WTC2025 in San Francisco, August 2 - 6. Join us for special events highlighting the latest in transplant innovation, including a tour of our local #Natera lab. RSVP: ow.ly/AKMq50WsQkq #Natera #TransplantCare @astschimera @ast_info @ttsorg
Dr. Jodi Regan, Director of Maternal-Fetal Medicine at Akron Children's, shares how using Natera’s fetal RhD NIPT helps her better prioritize supplies & provide the information Rh negative patients need to choose treatment. #Natera ow.ly/ywsH50Waih5 #RhD #PrenatalCare
Join our upcoming webinar, An overview of Signatera circulating tumor DNA (ctDNA) monitoring for solid organ transplant, feat. Michael Krainock, MD, PhD, associate medical director of oncology at #Natera. This webinar will explore the potential uses of #MRD monitoring in the…
Genetic testing company $NTRA celebrating 10 years on the Nasdaq. CEO Steve Chapman discusses the company’s latest developments in cancer detection: cnb.cx/4eBVFhz
🌿 Precision medicine. 🔬 @NateraGenetics is on a mission to transform the management of disease worldwide through personalized diagnostics. 🥳 Congrats on 10 years being #NasdaqListed—here’s to the next 10!
Welcoming @NateraGenetics to the @NasdaqExchange Opening Bell.
📚🧬Calling all future genetic counselors! #Natera is excited to host the upcoming virtual series featuring our popular Boards trivia, Bayes review, and group study events! Learn more and register for July sessions today: ow.ly/Lfpy50Wj8Yg
Hello from Barcelona! 👋 Speak to our team at booth 15 here at @myESMO Gastrointestinal Cancers Congress 2025! Don't miss our oral abstracts and poster presentations. #ESMOGI25 #Natera Learn more: ow.ly/jil450WjX4h
We’re excited to present at #ESMOGI25 - European Society for Medical Oncology Gastrointestinal Cancers Congress. These presentations highlight the continued clinical value of Signatera for molecular residual disease (MRD) assessment across colorectal and rectal cancers, including…
Check out this #ISHLTVoices podcast episode, presented by @NateraNeph, on the evolution of #ddcfDNA testing and noninvasive rejection monitoring post-#HeartTransplantation. 🫀 🎧 LISTEN NOW at 🔗 bit.ly/4lnW9K2, Spotify, Apple Podcasts 🎧 #DQS #ProsperaHeart
Join the upcoming AI in Precision Oncology webinar on July 1, sharing recent data on the utility of #MRD testing in management of breast cancer. 🧬 Register today: ow.ly/RR3p50WfJaE @liebertpub
🌎 Natera’s 2024 Sustainability Report is now live! This report reflects the efforts of teams across Natera to help reduce environmental impact, support our communities and foster a culture of belonging, while expanding access to our technology for more patients than ever before.…
Join the upcoming AI in Precision Oncology webinar on July 1, sharing recent data on the utility of #MRD testing in management of breast cancer. 🧬 Register today: ow.ly/hR6l50WeSkM @liebertpub
Join the upcoming AI in Precision Oncology webinar on July 1, sharing recent data on the utility of #MRD testing in management of breast cancer. 🧬 Register today: ow.ly/iKfr50Wb5cK @liebertpub
Later this month, Natera celebrates five years since opening lab operations in Austin. In those five years, our Austin team has delivered critical insights that support timely, informed decisions for patients and clinicians around the world. Behind every test is a team of…
❤️ One year of progress ❤️ One year of partnership ❤️ One year of Prospera Heart with DQS Learn more: ow.ly/8MOP50Wb3pu